Physician profile
Sheryl Abrams
NPI 1609115831
$3,280.42
in general payments reported to CMS, 2019-2025
25 companies · $821 in 2025
The $821 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $405 · 2022: $579 · 2023: $917 · 2024: $559 · 2025: $821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,296.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $699.45 | 2021-2024 | Watchman Access System, Watchman Flx, Wavewriter Alpha Prime 16 |
| Impulse Dynamics (USA) INC. | $377.12 | 2022-2024 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $366.17 | 2021-2025 | Farxiga, Fasenra |
| Novo Nordisk INC | $290.74 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Kestra Medical Technology Services, INC. | $238.56 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $213.90 | 2022-2025 | Lifevest |
| Amgen INC. | $148.85 | 2021-2023 | Repatha |
| Pfizer INC. | $148.59 | 2023-2025 | |
| United Therapeutics Corporation | $125.00 | 2021 | |
| Amarin Pharma, INC. | $99.00 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $94.44 | 2024-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $82.74 | 2022-2025 | Verquvo |
| Abbott Laboratories | $47.04 | 2022-2023 | Mitraclip |
| Astellas Pharma US INC | $46.40 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $40.94 | 2023 | Xarelto |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $40.11 | 2024 | |
| Esperion Therapeutics, INC. | $37.87 | 2024 | Nexletol |
| Baxter Healthcare | $31.61 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Daiichi Sankyo INC. | $26.72 | 2024 | Injectafer |
| Abiomed | $25.72 | 2023 | Impella |
| Lexicon Pharmaceuticals, INC. | $23.45 | 2024 | |
| Sanofi-Aventis U.S. LLC | $21.94 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $21.50 | 2024 | Evkeeza |
| Inari Medical, INC. | $16.66 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bayer Healthcare Pharmaceuticals INC. | $15.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheryl Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.